Overview
Phenylalanine is an essential aromatic amino acid that cannot be synthesized by the human body and must be obtained through diet. It contains a benzyl side chain, making it hydrophobic and structurally important in proteins. Phenylalanine serves as a fundamental building block for protein synthesis and plays a crucial role in brain function.
It is the precursor of tyrosine, which is further used in the synthesis of neurotransmitters such as dopamine, norepinephrine, and epinephrine, as well as melanin for pigmentation. Phenylalanine exists in L-, D-, and DL-forms, with L-phenylalanine being the biologically active form. In normal metabolism, phenylalanine is converted to tyrosine by the enzyme phenylalanine hydroxylase with tetrahydrobiopterin as a cofactor.
Symptoms
Abnormal phenylalanine levels mainly affect the nervous system and overall development. Excess phenylalanine leads to severe neurological manifestations such as intellectual disability, seizures, developmental delay, behavioral problems, hyperactivity, and poor cognitive function. A characteristic musty or mousy body odor may be present due to the accumulation of phenylalanine metabolites. Skin, hair, and eye hypopigmentation can occur due to reduced melanin synthesis.
In pregnant women with uncontrolled high phenylalanine levels, fetal complications such as microcephaly, congenital heart defects, and growth retardation may develop. Deficiency of phenylalanine may present with lethargy, apathy, poor alertness, low mood, hypotension, hypopigmentation, poor growth, and thyroid hormone deficiency.
Causes
Elevated phenylalanine levels are most commonly caused by phenylketonuria, a genetic disorder resulting from a deficiency of phenylalanine hydroxylase or defects in tetrahydrobiopterin metabolism. This leads to impaired conversion of phenylalanine to tyrosine and accumulation of toxic metabolites such as phenylpyruvate.
Secondary elevation may occur in liver disease or due to excessive dietary intake. Low phenylalanine levels may be caused by inadequate dietary intake, malnutrition, malabsorption, chronic illness, or increased metabolic demand. Artificial sweeteners containing aspartame contribute phenylalanine and can worsen levels in susceptible individuals.
Risk Factors
Risk factors for abnormal phenylalanine levels include inherited metabolic disorders such as phenylketonuria, family history of metabolic disease, and lack of newborn screening. Infants and children are particularly vulnerable due to the impact on brain development. Pregnant women with poorly controlled phenylalanine levels are at high risk of maternal phenylalanine syndrome affecting the fetus. Dietary exposure to aspartame-containing products increases risk in individuals with phenylalanine metabolism defects. Improper sample collection or delayed diagnosis may also contribute to adverse outcomes.
Prevention
Prevention focuses on early detection and lifelong management of phenylalanine levels. Newborn screening using dried blood spots allows early diagnosis of phenylketonuria and prevents irreversible neurological damage. Strict dietary restriction of phenylalanine with specialized medical nutrition therapy is essential for affected individuals. Regular monitoring of blood phenylalanine levels helps maintain safe concentrations, especially during childhood and pregnancy.
Avoiding aspartame-containing foods and proper dietary counseling reduce complications. Early intervention, continuous follow-up, and adherence to treatment protocols help ensure normal growth, development, and quality of life.
